Business Review

 
News Articles for Business Review top ^
2013/12/9
Virtusa Corporation  (NASDAQ: VRTU), a global business consulting and IT outsourcing company that combines innovation, technology leadership and industry solutions to transform the customer experience, today announced that it has been honored by The Albany Business Review as one of Albany’s Best Places to Work.
Sign-up for Virtusa Named to List of Best Places to Work by The Albany Business Review investment picks
2014/3/7
NH Customers Recognize Comcast for Reliable and Innovative Services MANCHESTER, N.H. , March 7, 2014 /PRNewswire/ -- Comcast today announced that the readers of New Hampshire Business Review voted to select Comcast Business as the number one telecommunications provider in the Granite State as part of the publication's Best of Business (BOB) Awards program.
Sign-up for New Hampshire Business Review Readers Vote Comcast #1 Telecommunications Provider In The Granite State investment picks
2014/3/14
BUNAVAIL PDUFA date June 7, 2014; Plans underway for potential Q3 2014 launch Positive results announced for Phase 3 clinical trial of BEMA Buprenorphine in opioid naive patients; results in opioid experienced patients expected mid-2014 Clonidine Topical Gel Phase 3 program initiated; study completion expected by year-end 2014 $60 million equity financing in February solidified balance sheet RALEIGH, N.C. , March 14, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2013 with the U.S. Securities and Exchange Commission and, in connection therewith, is providing a review of BDSI's 2013 financials and achievements as well as an update on business operations and upcoming milestones for 2014.
Sign-up for BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2013 Annual Report investment picks
2013/11/12
BUNAVAIL NDA Filed; PDUFA date June 7, 2014 Results of initial Phase 3 clinical trial of BEMA Buprenorphine for chronic pain expected early 2014 Clonidine Topical Gel Phase 2B confirmatory trial expected to begin 1Q14 RALEIGH, N.C. , Nov.
Sign-up for BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Third Quarter 2013 Financials investment picks
BUNAVAIL NDA submitted to FDA; first buccal film to compete in growing opioid dependence marketplace Phase 3 studies for BEMA Buprenorphine for chronic pain on track for completion and data read out by early 2014 Clonidine Topical Gel for Painful Diabetic Neuropathy to initiate Phase 2b study by year-end Cash runway through end of 2014 RALEIGH, N.C. , Aug.
Sign-up for BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Second Quarter 2013 Financials investment picks
2013/12/19
Oxygen Biotherapeutics, Inc.,(“OBI”) (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that it has filed its Quarterly Report on Form 10-Q for its second quarter fiscal year (FY) 2014 ended October 31, 2013.
Sign-up for Oxygen Biotherapeutics Provides a Business Review and Update in Conjunction with Filing of Second Quarter Fiscal Year 2014 Financials investment picks
CBRE Group, Inc. (NYSE:CBG) announced today that the Company will webcast presentations from its annual Business Review Day in New York City on Thursday, November 21, 2013 beginning at 9:00 a.m. Eastern Time.
Sign-up for CBRE Group, Inc. to Webcast Business Review Day Presentations investment picks
2014/2/19
ST. LOUIS , Feb.
Sign-up for Sigma-Aldrich Corporation Will Hold Its Annual Business Review March 12, 2014 investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Business Review
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Business Results  |  Next: Business Sales